Csl Ltd Sponadr Stock Fundamentals
| CSJA Stock | EUR 85.50 2.50 2.84% |
CSL LTD SPONADR fundamentals help investors to digest information that contributes to CSL's financial success or failures. It also enables traders to predict the movement of CSL Stock. The fundamental analysis module provides a way to measure CSL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CSL stock.
CSL |
CSL LTD SPONADR Company Operating Margin Analysis
CSL's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current CSL Operating Margin | 0.28 % |
Most of CSL's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CSL LTD SPONADR is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, CSL LTD SPONADR has an Operating Margin of 0.2809%. This is 100.8% lower than that of the Healthcare sector and 100.25% lower than that of the Biotechnology industry. The operating margin for all Germany stocks is 105.1% lower than that of the firm.
CSL LTD SPONADR Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CSL's current stock value. Our valuation model uses many indicators to compare CSL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CSL competition to find correlations between indicators driving CSL's intrinsic value. More Info.CSL LTD SPONADR is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.41 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for CSL LTD SPONADR is roughly 2.46 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CSL's earnings, one of the primary drivers of an investment's value.CSL Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CSL's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CSL could also be used in its relative valuation, which is a method of valuing CSL by comparing valuation metrics of similar companies.CSL is currently under evaluation in operating margin category among its peers.
CSL Fundamentals
| Return On Equity | 0.2 | |||
| Return On Asset | 0.0798 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | 0.28 % | |||
| Shares Outstanding | 964.43 M | |||
| Shares Owned By Institutions | 0.07 % | |||
| Price To Earning | 33.28 X | |||
| Revenue | 10.56 B | |||
| Gross Profit | 5.73 B | |||
| EBITDA | 3.32 B | |||
| Net Income | 1.8 B | |||
| Cash And Equivalents | 668.7 M | |||
| Cash Per Share | 0.74 X | |||
| Total Debt | 4.65 B | |||
| Debt To Equity | 95.80 % | |||
| Current Ratio | 2.93 X | |||
| Book Value Per Share | 15.13 X | |||
| Cash Flow From Operations | 1.6 B | |||
| Earnings Per Share | 2.24 X | |||
| Number Of Employees | 30 K | |||
| Beta | 0.18 | |||
| Market Capitalization | 95.48 B | |||
| Z Score | 12.0 | |||
| Annual Yield | 0.01 % | |||
| Last Dividend Paid | 2.22 |
About CSL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CSL LTD SPONADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CSL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CSL LTD SPONADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia. CSL LTD operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in CSL Stock
CSL financial ratios help investors to determine whether CSL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSL with respect to the benefits of owning CSL security.